<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AThird-party_consent</id>
	<title>Definition:Third-party consent - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AThird-party_consent"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Third-party_consent&amp;action=history"/>
	<updated>2026-06-14T17:25:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Third-party_consent&amp;diff=18045&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Third-party_consent&amp;diff=18045&amp;oldid=prev"/>
		<updated>2026-03-15T16:33:10Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🤝 &amp;#039;&amp;#039;&amp;#039;Third-party consent&amp;#039;&amp;#039;&amp;#039; is the formal approval required from an external party — neither the buyer nor the seller — before certain actions in an insurance transaction or contractual arrangement can proceed. In insurance [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] and corporate restructurings, the need for third-party consents frequently arises because insurance businesses operate within dense webs of contractual relationships: [[Definition:Binding authority agreement | binding authority agreements]] with [[Definition:Insurance carrier | carriers]], [[Definition:Reinsurance | reinsurance]] treaties, [[Definition:Broker | brokerage]] appointments, outsourced [[Definition:Claims management | claims handling]] contracts, technology licenses, and bank credit facilities often contain anti-assignment or [[Definition:Change of control | change-of-control]] clauses that require the counterparty&amp;#039;s consent before the agreement can transfer or remain in effect under new ownership.&lt;br /&gt;
&lt;br /&gt;
📋 Identifying and securing third-party consents is a critical workstream in any insurance deal&amp;#039;s [[Definition:Due diligence | due diligence]] and pre-closing execution phase. The buyer&amp;#039;s advisers will review the target&amp;#039;s material contracts to catalogue every consent requirement, assess the risk that a counterparty might withhold consent or use the leverage to extract better terms, and prioritize outreach accordingly. In practice, the most sensitive consents in insurance transactions involve [[Definition:Capacity | capacity]] providers — if a carrier relationship that underpins a [[Definition:Managing general agent (MGA) | MGA&amp;#039;s]] [[Definition:Book of business | book of business]] requires consent for a change of control, and the carrier is reluctant or slow to grant it, the deal can stall or collapse. Reinsurance treaty consents pose similar challenges, particularly for [[Definition:Quota share | quota share]] arrangements where the reinsurer has underwritten the risk based on confidence in the ceding company&amp;#039;s existing management team. The [[Definition:Share purchase agreement (SPA) | share purchase agreement]] typically addresses consent risk through conditions precedent (requiring key consents before closing) or through indemnification provisions that allocate the economic cost of lost contracts if consents are not obtained.&lt;br /&gt;
&lt;br /&gt;
⚠️ Regulatory approvals represent another layer of third-party consent that is especially prominent in insurance. Most jurisdictions require prior approval from the insurance regulator for any change of control of a licensed [[Definition:Insurance carrier | insurer]] — in the United States, this involves filings under the Insurance Holding Company System Regulatory Act with the relevant state insurance departments; in the EU, [[Definition:Solvency II | Solvency II]] Directive provisions govern qualifying holdings; and in markets like Hong Kong and Singapore, the [[Definition:Insurance Authority (IA) | Insurance Authority]] or [[Definition:Monetary Authority of Singapore (MAS) | MAS]] must approve significant ownership changes. Unlike commercial counterparty consents, regulatory approvals are non-negotiable and cannot be waived by the parties. The timeline for obtaining regulatory consent varies widely — from weeks for straightforward transactions in well-staffed regulatory jurisdictions to many months for complex cross-border deals — and frequently dictates the overall transaction timeline. Failure to anticipate and manage both commercial and regulatory third-party consent requirements is one of the most common sources of delay and value destruction in insurance M&amp;amp;A.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Change of control]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Share purchase agreement (SPA)]]&lt;br /&gt;
* [[Definition:Binding authority agreement]]&lt;br /&gt;
* [[Definition:Regulatory approval]]&lt;br /&gt;
* [[Definition:Termination right]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>